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     Generation of collagen dipeptides and deposition of orally administered 2 
prolylhydroxyproline (Pro-Hyp) in local inflammatory sites were examined in mice 3 
with hapten (2,4-dinitrofluorobenzene)-induced dermatitis in the ear. Pro-Hyp content in 4 
the hapten-treated ear was significantly higher in the chronic phase of contact dermatitis 5 
than the vehicle control. In contrast, hydroxyprolylglycine (Hyp-Gly) contents remained 6 
at lower levels in all cases compared to Pro-Hyp. Four hours after the ingestion of 7 
[13C5,15N]Pro and [13C5,15N]Pro-Hyp, labeled-Pro-Hyp and Pro, respectively, appeared 8 
only in the ear with dermatitis. Thus, Pro-Hyp is generated and degraded as part of the 9 
rapid synthesis and degradation of collagen in the ear with dermatitis. In addition to the 10 
endogenously generated Pro-Hyp, the orally administered Pro-Hyp was deposited in the 11 
ears.  12 
 13 
Key words: collagen peptide; prolylhydroxyproline; hydroxyprolylglycine; dermatitis; 14 
inflammation. 15 
 16 




     Collagen is one of the main protein components in the extracellular matrix and is 2 
the most abundant protein in the body comprising about one-third of the total protein.1) 3 
Heat-denatured collagen extracted from skin, bone or fish scale is referred to as gelatin. 4 
Collagen peptide, prepared by limited digestion of gelatin with proteases, is widely used 5 
as a food supplement to improve conditions pertaining to the skin and joints. Recent 6 
placebo-controlled double-blind trials have demonstrated that ingestion of collagen 7 
peptide significantly improves skin and joint conditions.2-4) Preclinical studies using 8 
animal models have also demonstrated that ingestion of collagen peptide or gelatin 9 
thickens collagen fibrils,5,6) promotes healing of pressure ulcers7) and bone fracture,8) 10 
and increases bone mineral density.9,10)  11 
   Presence of food-derived collagen oligopeptides in human peripheral blood after the 12 
ingestion of collagen peptide has been studied.11-14) Prolylhydroxyproline (Pro-Hyp) has 13 
been identified as major constituents of food-derived collagen peptide in human 14 
blood.11,12,14) Pro-Hyp has been demonstrated to stimulate the growth of primary 15 
cultured mouse skin fibroblasts on collagen,15) enhance the production of hyaluronic 16 
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acid by human skin fibroblasts,16) modulate lipid metabolism in adipocytes,17) and 1 
suppress mineralization in chondrocytes.18) Another collagen-derived dipeptide, 2 
hydroxyprolylglycine (Hyp-Gly), was also reported to stimulate growth of skin 3 
fibroblasts on collagen.13) These studies suggest that the beneficial effects of ingestion 4 
of collagen peptide depends, at least in part, on the biological activities of these 5 
collagen oligopeptides. 6 
   Free and peptide forms of Hyp have been detected in the urine of growing 7 
children,19) patients with bone tumors,20) and rheumatoid arthritis patients.21) These 8 
studies indicate that collagen peptides are generated by extensive degradation of 9 
extracellular matrix and under systemic inflammation. In the restricted site with 10 
inflammation or damage, Pro-Hyp may be locally generated, which can stimulate 11 
fibroblast growth for tissue repair and reconstruction of the extracellular matrix. 12 
However, local production of collagen oligopeptides at the damaged site has not been 13 
reported. 14 
   The objectives of the present study were to detect the local generation of Pro-Hyp 15 
and Hyp-Gly in the restricted site with inflammation and to detect the deposition of 16 
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orally administered Pro-Hyp by using mice with hapten-induced contact dermatitis in 1 
the ear. 2 
 3 
Materials and Methods 4 
    Chemicals. Pro-Hyp and Hyp-Gly were obtained from Bachem (Bubendorf, 5 
Switzerland). [13C5,15N]Pro-Hyp and [13C5,15N]Pro were obtained from Anygen, 6 
(Jeollanam-do, Korea) and Cambridge Isotope Laboratories (Tewksbury, MA, USA), 7 
respectively. 2,4-Dinitrofluorobenzene (DNFB) was obtained from Sigma-Aldrich (St. 8 
Louis, MO, USA). All reagents were of analytical grade or better. 9 
  Animal experiments. All animal experiments in this study were approved by the 10 
Ethics Committee of Nippi (Tokyo, Japan) and were carried out in the animal facilities 11 
of Nippi. Specific pathogen-free female BALB/cAJcl mice (age, 7 weeks) were 12 
purchased from CLEA Japan (Tokyo, Japan) and maintained at 23°C±5°C on a 13 
12-h/12-h light-dark cycle throughout the experimental period. The mice were fed a 14 
standard diet (MF; Oriental Yeast, Tokyo, Japan). One day before the determination of 15 
collagen dipeptide contents (for Pro-Hyp and Hyp-Gly), the diet was changed to 16 
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collagen-free AIN-93M (Oriental Yeast). Mice were given tap water ad libitum.  1 
   Induction of allergic contact dermatitis was performed by the method described by 2 
Kusubata et al.22) Briefly, after 1 week of acclimatization, the mice were treated with 10 3 
µL of 0.2% DNFB in acetone every 3 days to both dorsal and ventral sides of the right 4 
ear for 9 or 18 days to induce allergic contact dermatitis. Control mice received the 5 
treatment with acetone. Ear thickness was measured using a dial thickness gauge (Ozaki 6 
MFG, Tokyo, Japan) to evaluate development of edema by contact dermatitis 23).  7 
   To estimate the absorption of Pro-Hyp into blood, Pro-Hyp was orally administered. 8 
The diet was changed from MF to AIN-93M (collagen-free) in the morning on the day 9 
prior to Pro-Hyp administration, and the mice were fasted overnight. Pro-Hyp was 10 
dissolved in water at a concentration of 1 mg/mL and orally administered to mice via 11 
gavage (400 µg·400 µL-1·20 g body weight-1). This dose was employed on the basis of 12 
our previous human trial (collagen peptide 0.2 g·kg body weight-1·day-1)5,6) and the 13 
frequency of Pro-Hyp motif in collagen (10%). After Pro-Hyp administration, the mice 14 
were allowed to ingest AIN-93M ad libitum. Blood was collected 0, 0.5, 1, 2, 4 h after 15 
administration.  16 
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   To detect the deposition of orally administered Pro-Hyp in the ear, stable isotope 1 
labeled [13C5,15N]Pro-Hyp or [13C5,15N]Pro were administered to mice receiving DNFB 2 
application on the right ear. The diet was changed from MF to AIN-93M on day 17 as 3 
described above, and mice were fasted overnight. On day 18, 400 µg·400 µL/20 g body 4 
weight of the labeled Pro-Hyp or Pro in water was administered to mice via gavage. 5 
Ears were collected 4 h after the administration. 6 
 7 
    Preparation of plasma and ear samples. Mice were anesthetized with diethyl ether 8 
and blood samples were collected from the left ventricle by using a heparinized needle 9 
and syringe. After centrifugation at 12,000 rpm for 20 min at 4°C, plasma was collected 10 
and stored at −80°C until use. Plasma samples were mixed with three volumes of 11 
ethanol. The resultant precipitate was removed by centrifugation. The supernatant was 12 
diluted in 20 volumes of 0.1% formic acid and subjected to liquid 13 
chromatography-tandem mass spectrometry (LC-MS/MS) analysis.  14 
   The ears were excised and stored in 10 volumes of 70% ethanol at −80°C until use. 15 
They were cut into small pieces by using scissors and homogenized with a BioMasher 2 16 
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(Nippi, Tokyo, Japan) in 70% ethanol. After centrifugation at 12,000 rpm for 20 min at 1 
4°C, the supernatant was collected and dried using a centrifugal concentrator. The dried 2 
material was dissolved in 0.4 mL of 0.1% formic acid and centrifuged at 12,000 rpm for 3 
20 min at 4°C. The supernatant was filtrated through a 0.45-µm membrane filter and 4 
subjected to LC-MS/MS analysis. 5 
 6 
    LC-MS/MS analysis. Multiple reaction monitoring (MRM) was carried out to 7 
determine the amount of each compound by using 3200 QTRAP (AB Sciex, 8 
Framingham, MA, USA) equipped with HPLC Agilent1200 (Agilent, Santa Clara, CA, 9 
USA), monitoring the transition of m/z 235–75 (13C5,15N-Pro-Hyp), m/z 229–70 10 
(Pro-Hyp), m/z 189–86 (Hyp-Gly), m/z 132–68 (Hyp), m/z 122–75 (13C5,15N-Pro), and 11 
m/z 116–70 (Pro). HPLC was performed according to Yoshida et al.24) with minor 12 
modifications. The ion source was set with values of curtain gas of 15.0 psi, collision 13 
gas of 5 psi, ion spray voltage of 3,000 V, temperature of 600°C, ion source gas 1 of 80 14 
psi, and ion source gas 2 of 80 psi. The peak area was calculated using Analyst 1.5 (AB 15 
Sciex, Framingham, MA, USA).  16 
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     Statistical analysis. Statistical differences illustrated in Fig. 2 were detected using 1 
the Tukey–Kramer test, and the difference was considered to be significant when p < 2 
0.05. Statistical differences illustrated in Fig. 4 were assessed using the paired t-test, and 3 
p < 0.05 was considered significant.  4 
 5 
Results 6 
    Endogenous generation of Pro-Hyp in the ear with dermatitis. Temporal changes 7 
in the thickness of DNFB- and vehicle-treated ears are shown in Fig. 1. Treatment with 8 
the vehicle did not induce thickening of the ear. In contrast, repeated treatment with 9 
DNFB induced a marked increase in ear thickness in the acute phase (days 3–12). In the 10 
chronic phase (after day 15), the ear thickness decreased slightly and remained constant 11 
thereafter as reported previously.22) Thus, contact allergic dermatitis was induced in the 12 
right ear. The mice in this experiment were fed collagen-free diet and subjected to 13 
detection of Pro-Hyp and Hyp-Gly in the ears. 14 
   As shown in Fig. 2A and C, there was no significant difference in Hyp-Gly content 15 
between the DNFB- and vehicle-treated groups in the acute (day 9) and chronic phases 16 
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(day 18). Higher contents of Pro-Hyp compared to Hyp-Gly were detected even in the 1 
non-treated left ears (Fig. 2A and B). Pro-Hyp content in the DNFB-treated right ear 2 
increased to approximately 2-fold in the acute phase (day 9) and 7-fold in the chronic 3 
phase (day 18) compared to the vehicle-treated right ear (Fig. 2D). 4 
     Metabolism of orally administered Pro-Hyp and Pro in the ear. To evaluate the 5 
deposition of orally administered Pro-Hyp in ears, Pro-Hyp levels in the plasma after 6 
ingestion of Pro-Hyp at 400 µg/20 g body weight was first examined. As shown in Fig. 7 
3, plasma Pro-Hyp levels increased sharply 0.5 h after administration and returned to 8 
the initial levels 4 h after administration. Therefore, deposition of orally administered 9 
Pro-Hyp and Pro in the ear with the dermatitis was examined 4 h after oral 10 
administration. As shown in Fig. 4A and B, no significant amounts of the labeled 11 
Pro-Hyp and Pro were detected in the ears from either side in mice receiving water. 12 
Labeled Pro-Hyp (Fig. 4A) and Pro (Fig. 4B) were detected in the both DNFB-treated 13 
right ears and non-treated left ears after the administration of labeled Pro-Hyp and Pro, 14 
respectively. On the other hand, the labeled Pro-Hyp (Fig. 4A) and Pro (Fig. 4B) were 15 
specifically detected in the DNFB-treated right ears after the administration of labeled 16 
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Pro and Pro-Hyp, respectively.  1 
 2 
 Discussion 3 
      Under bone metastasis of cancer and chronic and systemic inflammatory 4 
disorders such as rheumatoid arthritis, increase in free Hyp and Hyp-containing peptides, 5 
including Pro-Hyp, in blood and urine have been reported.20,21) In such cases, extensive 6 
degradation of collagen occurs and the resultant collagen peptides can be detected in 7 
blood and urine. However, increase in these collagen oligopeptides in blood and urine 8 
from the animals and human suffering from local and restricted inflammation has not 9 
been reported. The present study demonstrates the local generation of Pro-Hyp in the 10 
right ear with dermatitis without affecting Pro-Hyp level in the normal left ear of the 11 
same animal. Hyp-Gly appears in human peripheral blood at a relatively high 12 
concentration after ingestion of collagen peptide.13) However, no significant increase of 13 
Hyp-Gly was observed in the mouse ears both with and without contact dermatitis, 14 
which might be explained by the reduced production of Hyp-Gly from collagen by 15 
mouse proteases and peptidases or rapid metabolism of Hyp-Gly.   16 
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   After ingestion of the stable isotope-labeled Pro-Hyp, the labeled Pro was detected 1 
only in the ear with dermatitis, indicating that prolidase, which splits dipeptides that 2 
contain carboxyl-terminal proline or hydroxyproline, is activated in the ear with the 3 
dermatitis. The activation and increase of prolidase in rat under inflammatory 4 
conditions have been reported.25) The present study also demonstrates that the stable 5 
isotope-labeled Pro is incorporated into the Pro-Hyp as early as within 4 h, but only in 6 
the ear with the dermatitis. This indicates that orally administered Pro is incorporated 7 
into collagen molecule and that Pro-Hyp is generated from the newly synthesized 8 
collagen within 4 h. The prolidase can, therefore, provide Pro for collagen synthesis. As 9 
part of this very rapid synthesis and degradation of collagen in the ear with dermatitis, 10 
collagen peptides are simultaneously generated and degraded, which results in specific 11 
and local increase of Pro-Hyp in the ear with dermatitis. 12 
    It has been reported that Pro-Hyp increases the number of fibroblasts migrated 13 
from the explanted mouse skin and that it enhances the proliferation of mouse skin 14 
fibroblasts on collagen gel; these have been considered as wound healing models.15) 15 
Therefore, Pro-Hyp that was locally generated at the inflammatory site can trigger 16 
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fibroblast growth for local tissue reconstruction. 1 
   Pro-Hyp appears as a major food-derived collagen peptide in human blood after the 2 
ingestion of collagen peptide.11) The present study also indicates that an increase in 3 
Pro-Hyp in mouse plasma after the ingestion of 0.02 g/kg Pro-Hyp, which is equivalent 4 
to 0.2 g/kg body weight of collagen peptide. The maximum level of Pro-Hyp in the 5 
plasma is approximately 2 µM, which is considerably lower compared to that in human 6 
plasma (approximately 20 µM) after the ingestion of similar dose of collagen peptide 7 
(10 g/serving).11) The plasma Pro-Hyp level returned to the initial level 4 h after the 8 
administration, after the orally administered Pro-Hyp was cleared from the plasma. 9 
However, the labeled Pro-Hyp remained in the ears both with and without dermatitis, 10 
which indicates that the orally administered Pro-Hyp deposits in the ear. Therefore, oral 11 
administration of collagen peptide can affect the Pro-Hyp level in the inflammatory site 12 
and cooperatively act with the endogenously generated Pro-Hyp on fibroblasts and other 13 
cells in the inflammatory site for the reconstruction of the extracellular matrix. In fact, 14 
oral administration of collagen peptide enhance wound healing of pressure ulcer in 15 
animal model possibly due to enhanced growth of fibroblast.26)  On the other hand, 16 
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effect of administration of collagen peptide on immune response itself remains to be 1 
solved. 2 
   As shown in Fig. 1, swelling occurred in the ear with dermatitis. Therefore, 3 
accumulation of Pro-Hyp-containing fluid in the ear with the dermatitis is expected. 4 
However, there is no significant difference in the level of labeled Pro-Hyp between the 5 
ear with and without dermatitis 4 h after the administration, which is partially explained 6 
by the specific degradation of Pro-Hyp by prolidase in the ear with dermatitis as 7 
discussed above. In addition, Kawaguchi et al. demonstrated that orally administered 8 
[14C] Pro-Hyp deposits in a peptide form in rat tissues and is rapidly converted into 9 
unidentified metabolites that were or were not susceptible to HCl hydrolysis 27). It is 10 
possible that Pro-Hyp is rapidly converted into these unidentified metabolites with some 11 
biological activities in the ear with dermatitis compared to the normal ear. To address 12 
these problems at the molecular level, it is necessary to identify the metabolites. 13 
Currently, further studies to identify the metabolites of Pro-Hyp and Hyp-Gly in animal 14 
tissues and in cultured fibroblast are underway.  15 
 16 




The authors are grateful to Dr. O. Hayashida for his valuable discussions.  2 
This work was partially supported by a JSPS Grant-in-Aid for Scientific Research (C) 3 
to Kenji Sato (No.23500966). 4 
 5 
References 6 
[1] Eastoe JE. Composition of collagen and allied proteins. In: Treaties on Collagen. 7 
Ramachandram GN ed, Academic Press, London and New York, 1976. 8 
[2] Clark KL, Sebastianelli W, Flechsenhar KR, Aukermann DF, Meza F, Millard RL, 9 
Deitch JR, Sherbondy PS, Albert A. 24-Week study on the use of collagen 10 
hydrolysate as a dietary supplement in athletes with activity-related joint pain. 11 
Curr. Med. Res. Opin. 2008;24:1485-1496.  12 
[3] Proksch E, Segger D, Degwert J, Schunck M, Zague V, Oesser S. Oral 13 
supplementation of specific collagen peptides has beneficial effects on human 14 
skin physiology: a double-blind, placebo-controlled study. Skin Pharmacol. 15 
Physiol. 2014; 27:47-55.  16 
Page 16 of 28Bioscience, Biotechnology, and Biochemistry
For Peer Review
 17 
[4] Proksch E, Schunck M, Zague V, Segger D, Degwert J, Oesser S. Oral intake of 1 
specific bioactive collagen peptides reduces skin wrinkles and increases dermal 2 
matrix synthesis. Skin Pharmacol. Physiol. 2014;27:113-119.   3 
[5] Matsuda N, Koyama Y, Hosaka Y, Ueda H, Watanabe T, Araya T, Irie S, Takehana K. 4 
Effects of ingestion of collagen peptide on collagen fibrils and 5 
glycosaminoglycans in the dermis. J. Nutr. Sci. Vitaminol. 2006;52:211-215. 6 
[6] Minaguchi J, Koyama Y, Meguri N, Hosaka Y, Ueda H, Kusubata M, Hirota A, Irie 7 
S, Mafune N, Takehana K. Effects of ingestion of collagen peptide on collagen 8 
fibrils and glycosaminoglycans in Achilles tendon. J. Nutr. Sci. Vitaminol. 9 
2005;51:169-174. 10 
[7] Nakao K, Kusubata M, Hara K. Igarashi m, Yamazaki N, Koyama Y. Effects of 11 
collagen peptide ingestion on healing of skin wound in a rat model of pressure 12 
ulcer. Jpn. Pharmacol. Ther. 2013;41:587-596. 13 
[8] Tsuruoka N, Yamamoto R, Sakai Y, Yoshitake Y, Yonekura H. Promotion by 14 
collagen tripeptide of type I collagen gene expression in human osteoblastic cells 15 
and fracture healing of rat femur. Biosci. Biotechnol. Biochem. 2007;71:2680–16 




[9] Koyama Y, Hirota A, Mori H, Takahara H, Kuwaba K, Kusubata M, Matsubara Y, 2 
Kasugai S, Itoh M, Irie S. Ingestion of gelatin has differential effect on bone 3 
mineral density and body weight in protein undernutrition. J. Nutr. Sci. Vitaminol. 4 
2001;47:84-86. 5 
[10] Wu J, Fujioka M, Sugimoto K, Mu G, Ishimi Y. Assessment of effectiveness of oral 6 
administration of collagen peptide on bone metabolism in growing and mature 7 
rats. Bone Miner. Metab. 2004;22:547-553. 8 
[11] Iwai K, Hasegawa T, Taguchi Y, Morimatsu F, Sato K, Nakamura Y, Higashi A, 9 
Kido Y, Nakabo Y, Ohtsuki K. Identification of food-derived collagen peptides in 10 
human blood after oral ingestion of gelatin hydrolysates. J. Agric. Food Chem. 11 
2005;53:6531-6536. 12 
[12] Ichikawa S, Morifuji M, Ohara H, Matsumoto H, Takeuchi Y, Sato, K. 13 
Hydroxyproline-containing dipeptides and tripeptides quantified at high 14 
concentration in human blood after oral administration of gelatin hydrolysate. Int. 15 
J. Food Sci. Nutri. 2010;61:52-60. 16 
Page 18 of 28Bioscience, Biotechnology, and Biochemistry
For Peer Review
 19 
[13] Shigemura Y, Akaba S, Kawashima E, Park EY, Nakamura Y, Sato K. Identification 1 
of a novel food-derived collagen peptide, hydroxyprolyl-glycine, in human 2 
peripheral blood by pre-column derivatisation with isothiocyanate. Food Chem. 3 
2011;129:1019-1024. 4 
[14] Ohara H, Matsumoto H, Ito K, Iwai K, Sato, K. Comparison of quantity and 5 
structures of hydroxyproline-containing peptides in human blood after oral 6 
ingestion of gelatin hydrolysates from different sources. J. Agric. Food Chem. 7 
2007;55:1532-1535. 8 
[15] Shigemura Y, Iwai K, Morimatsu F, Iwamoto T, Mori T, Oda C, Taira T, Park EY, 9 
Nakamura Y, Sato, K. Effect of prolyl-hydroxyproline (Pro-Hyp), a food-derived 10 
collagen peptide in human blood, on growth of fibroblasts from mouse skin. J. 11 
Agric. Food Chem. 2009;57:444-449. 12 
[16] Ohara H, Ichikawa S, Matsumoto H, Akiyama M, Fujimoto N, Kobayashi T, 13 
Tajima S. Collagen-derived dipeptide, proline-hydroxyproline, stimulates cell 14 
proliferation and hyaluronic acid synthesis in cultured human dermal fibroblasts. J. 15 
Dermatol. 2010;37:330-338. 16 
Page 19 of 28 Bioscience, Biotechnology, and Biochemistry
For Peer Review
 20 
[17] Minaguchi J, Tometsuka C, Koyama Y, Kusubata M, Nagayasu A, Sawaya S, Shiga 1 
T, Shima H, Hara T, Takehana K. Effects of collagen-derived oligopeptide 2 
prolylhydroxyproline on differentiation of mouse 3T3-L1 preadipocytes. Food Sci. 3 
Techinol. Res. 2012;18:593-599. 4 
[18] Nakatani S, Mano H, Sampei C, Shimizu J, Wada M. Chondroprotective effect of 5 
the bioactive peptide prolyl-hydroxyproline in mouse articular cartilage in vitro 6 
and in vivo. Osteoarthritis Cartilage 2009;17:1620-1627. 7 
[19] Ziff M, Kibrick A, Dresner E, Gribetzet J. Excretion of hydroxyproline in patients 8 
with rheumatic and non-rheumatic diseases. J. Clin. Invest. 1956;35:579-587. 9 
[20] Hosley HF, Taft EG, Olson KB, Gates S, Beebe RT. Hydroxyproline excretion in 10 
malignant neoplastic disease. Arch. Intern. Med. 1966;118:565-71. 11 
[21] Bienenstock H, Kibrick AC. Urinary excretion of prolylhydroxyproline in 12 
rheumatic diseases. Ann. Rheum. Dis. 1969;28:28-30. 13 
[22] Kusubata M, Hirota A, Ebihara T, Kuwaba K, Matsubara Y, Sasaki T, Kusakabe M, 14 
Tsukada T, Irie S, Koyama Y. Spatiotemporal changes of fibronectin, tenascin-C, 15 
fibulin-1, and fibulin-2 in the skin during the development of chronic contact 16 
Page 20 of 28Bioscience, Biotechnology, and Biochemistry
For Peer Review
 21 
dermatitis. J. Invest. Dermatol. 1999;113:906-912. 1 
[23] Gorbachev AV, Fairchild RL. Induction and regulation of T-cell priming for contact 2 
hypersensitivity. Crit. Rev. Immunol. 2001;21:451-472. 3 
[24] Yoshida H, Mizukoshi T, Hirayama K, Miyano H. Comprehensive analytical 4 
method for the determination of hydrophilic metabolites by high-performance 5 
liquid chromatography and mass spectrometry. J. Agric. Food Chem. 6 
2007;55:551-560. 7 
 [25] Imai K, Nagatsu T, Yajima T, Maeda N, Kumegawa M, Kato T. Developmental 8 
changes in the activities of prolinase and prolidase in rat salivary glands, and the 9 
effect of thyroxine administration. Mol. Cell Biochem. 1982;42:31-36. 10 
[26] Nakao K, Kusubata M, Hara K, Igarashi, M, Yamazaki N, Koyama Y. Effects of 11 
collagen peptide ingestion on healing of skin wound in a rat model of pressure 12 
ulcer. Jpn. Pharmacol. Ther. 2013;41:587-595. 13 
[27] Kawaguchi T, Nanbu PN, Kurokawa M. Distribution of prolylhydroxyproline and 14 
its metabolites after oral administration in rats. Biol. Pharm. Bull. 15 
2012;35:422-427. 16 
Page 21 of 28 Bioscience, Biotechnology, and Biochemistry
For Peer Review
 22 
Figure legends 1 
Fig. 1. Induction of contact dermatitis 2 
Contact dermatitis was induced by applying DNFB or vehicle every 3 days to the right 3 
ear of mice and the temporal changes of ear thickness were measured. The results are 4 
presented as mean ± SD (n=6).  5 
 6 
Fig.2. Contents of Hyp-Gly and Pro-Hyp in mouse ear 7 
(A, B): Hyp-Gly (A) and Pro-Hyp (B) in the non-treated left ear of mice treated with 8 
vehicle (V) or DNFB on the right ear for 9 or 18 days. (C, D): Hyp-Gly (C) and 9 
Pro-Hyp (D) in the right ear treated with vehicle (V) or DNFB for 9 or 18 days. The 10 
results are presented as mean ± SD (n=6). Values in the same figure not sharing a 11 
common letter above the bar are significantly different from each another, p < 0.05. 12 
 13 
Fig. 3. Pro-Hyp in plasma after ingestion of Pro-Hyp  14 
Pro-Hyp was orally administered at a dose of 400 µg/20 g body weight and measured in 15 
the plasma. The results are presented as mean ± SD (n=3) 16 
Page 22 of 28Bioscience, Biotechnology, and Biochemistry
For Peer Review
 23 
  1 
Fig. 4: Contents of [13C5,15N]Pro-Hyp and [13C5,15N]Pro in the ears of mice with contact 2 
dermatitis  3 
The right ear of mice was treated with DNFB (+) and the left ear was non-treated (−) for 4 
18 days. On day 18, the mice were orally administered water, [13C5,15N]Pro-Hyp or 5 
[13C5,15N]Pro, and the contents of the labeled Pro-Hyp (A) and Pro (B) in each ear were 6 
determined 4 h after ingestion (n=4). * p < 0.05.  7 
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Pro-Hyp was orally administered at a dose of 400 µg/20 g body weight and measured in the plasma. The 
results are presented as mean ± SD (n=3)  
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Fig. 4: Contents of [13C5,15N]Pro-Hyp and [13C5,15N]Pro in the ears of mice with contact dermatitis  
The right ear of mice was treated with DNFB (+) and the left ear was non-treated (−) for 18 days. On day 
18, the mice were orally administered water, [13C5,15N]Pro-Hyp or [13C5,15N]Pro, and the contents of the 
labeled Pro-Hyp (A) and Pro (B) in each ear were determined 4 h after ingestion (n=4). * p < 0.05.  
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